BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7877247)

  • 1. [Revaluation of current antimicrobials. Series 24: imipenem/cilastatin].
    Kohno S; Wada K
    Jpn J Antibiot; 1994 Dec; 47(12):1629-36. PubMed ID: 7877247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
    Oka S; Goto M; Kaji Y; Kimura S; Matsuda K; Asahi Y; Sanada M; Nakagawa S; Inoue M; Shimada K
    J Antimicrob Chemother; 1993 Apr; 31(4):533-41. PubMed ID: 8514648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    Kouda M
    Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.
    Ernst EJ; Hashimoto S; Guglielmo J; Sawa T; Pittet JF; Kropp H; Jackson JJ; Wiener-Kronish JP
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2389-94. PubMed ID: 10508012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistant S. aureus].
    Yokoyama T; Kodama T; Takesue Y; Fujimoto M; Murakami Y; Sewake H; Imamura Y; Okita M
    Jpn J Antibiot; 1990 Jan; 43(1):131-8. PubMed ID: 2348549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of MRSA infections].
    Inamatsu T
    Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1662-7. PubMed ID: 1469319
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
    Yamazaki Y; Hirai K; Honda T
    Scand J Infect Dis; 2002; 34(3):211-3. PubMed ID: 12030399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
    Totsuka K; Shiseki M; Kikuchi K; Matsui Y
    J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
    Petersen PJ; Jacobus NV; Weiss WJ; Testa RT
    Antimicrob Agents Chemother; 1991 Jan; 35(1):203-7. PubMed ID: 1901698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa-acquired resistance to imipenem-cilastatin: commentary on clinical implications of antibiotic resistance.
    Tidwell BH; Cleary JD
    Pharmacotherapy; 1993; 13(2):165; discussion 166. PubMed ID: 8469624
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty.
    Furuhata M; Iwamura M; Baba S; Inoue M
    Int J Urol; 2003 Apr; 10(4):228-30. PubMed ID: 12657103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
    Bonatti H; Guggenbichler JP; Hager J
    Infection; 1990; 18(5):302-6. PubMed ID: 2276826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 16. Imipenem-cilastatin sodium.
    Roach AC
    Crit Care Nurse; 1989 Mar; 9(3):14-8. PubMed ID: 2582800
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial activity of imipenem/cilastatin (thienam) against agents causing pyoseptic processes].
    Vasina TA; Kartavenko VI; Men'shikova ED; Shabanov AK; Mironov AV
    Khirurgiia (Mosk); 2002; (12):45-7. PubMed ID: 12522928
    [No Abstract]   [Full Text] [Related]  

  • 18. Imipenem-cilastatin.
    Dinsmoor MJ
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):475-82. PubMed ID: 1436925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
    Bégué P; Quinet B; Baron S; Challier P; Fontaine JL; Lasfargues G
    Pathol Biol (Paris); 1989 May; 37(5):485-90. PubMed ID: 2674874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of teicoplanin and imipenem on respiratory infections in high risk patients.
    Piu G; Aresu G; Pautasso M; Garau G; Melis S; Ceccio S; Morini M; Palomba A
    J Chemother; 1991 Jan; 3 Suppl 1():222-3. PubMed ID: 12041770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.